Novel role of the dietary flavonoid fisetin in suppressing rRNA biogenesis.
Lab Invest
; 101(11): 1439-1448, 2021 11.
Article
en En
| MEDLINE
| ID: mdl-34267320
ABSTRACT
The nucleolus of a cell is a critical cellular compartment that is responsible for ribosome biogenesis and plays a central role in tumor progression. Fisetin, a nutraceutical, is a naturally occurring flavonol from the flavonoid group of polyphenols that has anti-cancer effects. Fisetin negatively impacts several signaling pathways that support tumor progression. However, effect of fisetin on the nucleolus and its functions were unknown. We observed that fisetin is able to physically enter the nucleolus. In the nucleolus, RNA polymerase I (RNA Pol I) mediates the biogenesis of ribosomal RNA. Thus, we investigated the impacts of fisetin on the nucleolus. We observed that breast tumor cells treated with fisetin show a 20-30% decreased nucleolar abundance per cell and a 30-60% downregulation of RNA Pol I transcription activity, as well as a 50-70% reduction in nascent rRNA synthesis, depending on the cell line. Our studies show that fisetin negatively influences MAPK/ERK pathway to impair RNA Pol I activity and rRNA biogenesis. Functionally, we demonstrate that fisetin acts synergistically (CI = 0.4) with RNA Pol I inhibitor, BMH-21 and shows a noteworthy negative impact (60% decrease) on lung colonization of breast cancer cells. Overall, our findings highlight the potential of ribosomal RNA (rRNA) biogenesis as a target for secondary prevention and possible treatment of metastatic disease.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
ARN Polimerasa I
/
Nucléolo Celular
/
Flavonoles
/
Neoplasias de la Mama Triple Negativas
/
Neoplasias Pulmonares
Límite:
Animals
/
Humans
Idioma:
En
Año:
2021
Tipo del documento:
Article